Advancing progressive health policy to reduce NCDs amidst international commercial opposition: Tobacco standardised packaging in Australia

Global Public Health
Eric CrosbieStella Bialous

Abstract

This study examines how health advocates and the Australian government responded to international commercial pressure during the implementation of tobacco standardised packaging (SP) as a measure to reduce non-communicable diseases (NCDs). Relevant government and NGO documents, and media items were reviewed. Policymakers and health advocates (n = 19) in Australia were interviewed. In 2009, Australia's National Health Taskforce recommended SP, which the Australian government announced in April 2010. In response, tobacco companies threatened the government with litigation in both domestic and international courts, claiming that SP would violate their investment and intellectual property rights. However, these legal threats were unsuccessful in forcing the government to withdrawal the SP proposal. Tobacco companies legally challenged SP, but as of February 2018 failed with each legal challenge. The political success of enacting and implementing SP against international commercial pressure was supported by legal preparation and support, and a whole-of-government approach. The Australian SP case illustrates how, against international commercial opposition, governments can build and maintain political and official support to enact an...Continue Reading

References

Sep 12, 2000·Tobacco Control·R E Malone, E D Balbach
Apr 1, 1985·New Zealand Veterinary Journal·M B OrrS F Crosbie
Nov 10, 2010·Tobacco Control·Eric CrosbieStanton A Glantz
Nov 19, 2010·American Journal of Preventive Medicine·Robert A HahnUNKNOWN Task Force on Community Preventive Services
Sep 24, 2011·American Journal of Public Health·Hadii M MamuduStanton Glantz
Jan 19, 2012·JAMA : the Journal of the American Medical Association·Andrew D Mitchell, David M Studdert
Jun 23, 2012·PLoS Medicine·David Stuckler, Marion Nestle
Sep 7, 2012·Journal of Public Health Policy·Jeffrey Drope, Raphael Lencucha
Jun 7, 2013·Journal of Public Health Policy·Holly Jarman
Mar 1, 2014·Health Policy·Scott L Greer, Denise F Lillvis
Mar 8, 2014·Journal of Health Politics, Policy and Law·Jeffrey Drope, Raphael Lencucha
Aug 7, 2014·Health Policy and Planning·Raphael LencuchaJenina Joy Chavez
Aug 29, 2014·The Medical Journal of Australia·Mike Daube, Simon Chapman
May 7, 2015·Lancet·Raphael LencuchaJeffrey Drope
Jul 18, 2016·Globalization and Health·Julia SmithCase Gordon

❮ Previous
Next ❯

Citations

Sep 20, 2019·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Dharma N BhattaStanton Glantz
Jan 2, 2021·Asia-Pacific Journal of Public Health·Jae Hyung KimSungkyu Lee
Mar 18, 2021·Health Promotion International·Melis SelamoğluDeborah Gleeson
Jun 22, 2021·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Ana Clara DuranLindsey Smith Taillie
Aug 10, 2021·Global Public Health·Jeffery AdamsStephen Neville
Jul 1, 2020·International Journal of Nursing Studies·Dianna KidgellRuth Endacott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.